1994
DOI: 10.1093/rheumatology/33.7.668
|View full text |Cite
|
Sign up to set email alerts
|

An Open Access Bone Densitometry Service: Report of First Year's Operation

Abstract: Medical treatment of symptomatic osteoporosis is unsatisfactory. Treatment of patients with low bone density but without history of fracture includes hormone replacement therapy (HRT) which offers the prospect of reduced fracture risk. Dual energy X-ray absorptiometry (DXA) offers a safe and accurate technique available for the measurement of bone mineral density at a district general hospital level. All open access service providing densitometry measurements for general practitioners and hospital consultants … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

1996
1996
2014
2014

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…The major indications for DXA referral in our service were family history of osteoporosis or fracture, previous fractures and X-ray appearance of osteopenia. A previous report of the open access DXA service in South Tees Health District in 1991 by Fordham et al (22) showed that the main reasons for DXA referral were early menopause and patients deciding on hormone replacement therapy. This difference might be due to the availability of other treatments (such as etidronate licensed in 1992 and alendronate licensed in 1995 in the UK) and the GPs' greater awareness of other risk factors of osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…The major indications for DXA referral in our service were family history of osteoporosis or fracture, previous fractures and X-ray appearance of osteopenia. A previous report of the open access DXA service in South Tees Health District in 1991 by Fordham et al (22) showed that the main reasons for DXA referral were early menopause and patients deciding on hormone replacement therapy. This difference might be due to the availability of other treatments (such as etidronate licensed in 1992 and alendronate licensed in 1995 in the UK) and the GPs' greater awareness of other risk factors of osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…Various methods are available for measuring bone density like DEXA, Dual-photon absorptiometry (DPA) [11] [12], Quantitative ultrasound (QUS) [13] and Computed tomography (CT) [14] [15]. DEXA is currently considered the bone densitometric technique of choice [1] [2]. DEXA is found to have a low radiation exposure (less than 0.1 microGy) [16].…”
Section: Discussionmentioning
confidence: 99%
“…There is limited additional information on densitometry use from reviews of referral patterns to densitometry facilities. Data from a 1991 British study [15] and the 1996 U.S. randomized trial of bone density reporting [11] both identified risk factors for osteoporosis (including early menopause, family history of osteoporosis, medical conditions and steroid use) as the most common indication for densitometry. Other reasons were consideration of HRT, history of fracture, patient request and back pain.…”
Section: Discussionmentioning
confidence: 99%